Production (Stage)
Veracyte, Inc.
VCYT
$27.16
-$0.24-0.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 114.47M | 118.63M | 115.86M | 114.43M | 96.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 114.47M | 118.63M | 115.86M | 114.43M | 96.84M |
| Cost of Revenue | 32.38M | 37.07M | 33.93M | 33.61M | 31.46M |
| Gross Profit | 82.09M | 81.57M | 81.93M | 80.82M | 65.38M |
| SG&A Expenses | 53.12M | 50.81M | 48.35M | 55.16M | 49.99M |
| Depreciation & Amortization | 3.21M | 3.61M | 3.80M | 3.79M | 3.65M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.42M | 110.78M | 103.66M | 109.02M | 101.07M |
| Operating Income | 8.05M | 7.85M | 12.20M | 5.41M | -4.22M |
| Income Before Tax | 7.43M | 3.44M | 16.85M | 7.36M | -1.91M |
| Income Tax Expenses | 381.00K | -1.67M | 1.69M | 1.63M | -44.00K |
| Earnings from Continuing Operations | 7.05M | 5.11M | 15.16M | 5.73M | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.05M | 5.11M | 15.16M | 5.73M | -1.86M |
| EBIT | 8.05M | 7.85M | 12.20M | 5.41M | -4.22M |
| EBITDA | 13.41M | 14.11M | 18.08M | 11.14M | 1.37M |
| EPS Basic | 0.09 | 0.07 | 0.20 | 0.07 | -0.02 |
| Normalized Basic EPS | 0.10 | 0.06 | 0.14 | 0.07 | -0.01 |
| EPS Diluted | 0.09 | 0.06 | 0.19 | 0.07 | -0.02 |
| Normalized Diluted EPS | 0.10 | 0.06 | 0.14 | 0.07 | -0.01 |
| Average Basic Shares Outstanding | 78.03M | 77.61M | 77.01M | 76.54M | 74.76M |
| Average Diluted Shares Outstanding | 80.06M | 79.91M | 78.46M | 77.16M | 74.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |